Skip to main content
NanoRepro AG logo

NanoRepro AG — Investor Relations & Filings

Ticker · NN6 ISIN · DE0006577109 LEI · 3912008FCA63AGIMEV74 F Manufacturing
Filings indexed 415 across all filing types
Latest filing 2010-04-15 Regulatory Filings
Country DE Germany
Listing F NN6

About NanoRepro AG

https://www.nanorepro.com/en/

NanoRepro AG is a company specializing in the development, manufacturing, and distribution of CE-marked rapid diagnostic tests (self-tests) and food supplements. The products are designed for both home and professional use. The company's portfolio covers various health areas, including family planning, preventive healthcare, disease detection, food intolerances, allergies, and infectious diseases. The primary goal is to provide accuracy in self-diagnostics for rapid disease detection and health monitoring.

Recent filings

Filing Released Lang Actions
NanoRepro AG schliet exklusive Vertriebsvereinbarung fur die Turkei ab
Regulatory Filings Classification · 100% confidence The document is a short news release dated April 15, 2010, announcing that NanoRepro AG has concluded an exclusive distribution agreement for Turkey. It is a corporate announcement regarding a business development (a new partnership/agreement). This type of announcement, which details a specific business event rather than financial results (ER), management change (MANG), or capital structure change (CAP), fits best under the general regulatory announcement category, as it is not covered by the more specific codes like DIV, DIRS, or TAR. Given the options, 'Regulatory Filings' (RNS) serves as the appropriate fallback for general corporate news releases that don't fit a precise category, although it is a specific business update. Since there is no specific code for 'Business Development/Partnership Announcement', RNS is the most suitable general regulatory category provided.
2010-04-15 German
NanoRepro AG stellt FertiQUICK, den neuen Fruchtbarkeitstest fur den Mann, vor
Regulatory Filings Classification · 99% confidence The document is a short news release dated March 29, 2010, announcing the launch of a new product, 'FertiQUICK,' a male fertility test, by NanoRepro AG. It details the product's function, pricing, and availability, and includes a standard corporate disclaimer and contact information. This type of announcement, focusing on a new product introduction rather than financial results (ER), management changes (MANG), or capital structure (CAP), is best classified as a general regulatory announcement or news release that doesn't fit a more specific category. Since it is a general corporate news item distributed via DGAP (a common channel for regulatory news), and it is not a formal financial report (like 10-K or IR), the most appropriate fallback category is Regulatory Filings (RNS). The length (4234 chars) is short, but the content is a direct announcement, not an announcement *of* a report, so RPA is less suitable than RNS for general news.
2010-03-29 German
Datum:23.03.2010
Annual Report Classification · 95% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) for NanoRepro AG for the fiscal year 2008. It contains a balance sheet (Bilanz), notes to the financial statements (Anhang), and details on accounting methods, board members, and profit/loss appropriation. While it is an annual financial document, it is a standalone financial statement rather than a comprehensive 10-K style annual report (which typically includes management discussion and analysis, auditor reports, and extensive business descriptions). In the context of German corporate filings, this is classified as an Annual Report/Financial Statement. FY 2008
2010-03-23 German
Datum:08.03.2010
Audit Report / Information Classification · 98% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) for Oehmichen Optik AG for the fiscal year 2008. It contains a detailed balance sheet (Bilanz) and profit and loss statement (Gewinn- und Verlustrechnung). In the context of German corporate filings, this constitutes the core financial reporting component of an Annual Report. While it lacks the narrative management report (Lagebericht), it represents the primary financial data of the annual reporting cycle, fitting the 10-K classification for annual financial performance. FY 2008
2010-03-08 German
NanoRepro AG stellt neuen Schnelltest CholesterinCHECK vor
Regulatory Filings Classification · 99% confidence The document is a short news release dated January 25, 2010, announcing the launch of a new product, 'CholesterinCHECK', by NanoRepro AG. It is explicitly labeled as a 'Corporate News' and distributed via DGAP. The content focuses on a product introduction and market strategy, not on periodic financial results (ER/IR), regulatory filings (10-K/AR), or management changes (MANG). Since it is a general corporate announcement about a business event (product launch) that doesn't fit the highly specific categories like DIV, CAP, or DIRS, the most appropriate classification is the general regulatory announcement/news category, RNS (Regulatory Filings), as per the fallback rule for miscellaneous announcements.
2010-01-25 German
NanoRepro AG stellt neuen Schnelltest VagiQUICK vor
Regulatory Filings Classification · 100% confidence The document is a short news release dated January 15, 2010, announcing the launch of a new product, VagiQUICK, by NanoRepro AG. It is explicitly labeled as a 'Corporate News' and distributed via DGAP. It discusses a product introduction and its expected contribution to revenue growth, which is typical of a general corporate announcement rather than a formal financial filing like a 10-K, IR, or ER. Since it is a general corporate announcement about a business event (product launch) that doesn't fit the specific categories like M&A (TAR), Capital Change (CAP), or Director Dealing (DIRS), it falls best under the general Regulatory Filings/Announcements category (RNS), as it is a public disclosure of material business information.
2010-01-15 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.